Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apatinib in Metastatic Gastric Carcinoma
NCT00970138Phase 3Completed
- Sponsor
- Fudan University
- Start
- Jun 2009
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Rivoceranib in Gastric carcinoma (GC), sponsored by Fudan University. Started Jun 2009; status: completed.
02
Drugs
Rivoceranib
03
Conditions
Gastric carcinoma (GC)
Beyond the preview
Go deeper on NCT00970138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00970138.